Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1
Author:
Affiliation:
1. Shaanxi Key Laboratory of Brain Disorders and School of Basic Medical Science, Xi’an Medical University, Xi’an, Shaanxi, China
2. Institute of Basic and Translational Medicine, Xi’an Medical University, Xi’an, Shaanxi, China
Publisher
IOS Press
Subject
Cancer Research,Genetics,Oncology,General Medicine
Reference47 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Immunological landscape and immunotherapy of hepatocellular carcinoma;Prieto;Nature Reviews Gastroenterology & Hepatology,2015
3. Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials;Kudo;Oncology,2017
4. Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review;Ellis;Clin Lung Cancer,2017
5. Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy. Trends and perspectives;Mazzolini;Medicina (B Aires),2018
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LILRB1+ immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer;International Immunopharmacology;2023-06
2. Suppression of SAMSN1 contributes to neuroprotection in neonatal rats suffering from hypoxic–ischemic encephalopathy injury;Ibrain;2022-11-12
3. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer;Journal of Cancer Research and Clinical Oncology;2022-09-15
4. Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia;Molecular Therapy - Oncolytics;2022-09
5. Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer;World Journal of Surgical Oncology;2022-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3